Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yin-Ting Yang, Xi-Ya Jiang, Hong-Liang Xu, Guo Chen, Sen-Lin Wang, He-Ping Zhang, Lin Hong, Qin-Qin Jin, Hui Yao, Wei-Yu Zhang, Yu-Ting Zhu, Jie Mei, Lu Tian, Jie Ying, Jing-Jing Hu & Shu-Guang Zhou. (2023) Autoimmune Disease-Related Hub Genes are Potential Biomarkers and Associated with Immune Microenvironment in Endometriosis. International Journal of General Medicine 16, pages 2897-2921.
Read now
Read now
Articles from other publishers (25)
Manuel Montesinos-Rongen, Monica Sanchez-Ruiz, Susann Siebert, Claudia Winter, Reiner Siebert, Anna Brunn & Martina Deckert. (2023) AMD3100-Mediated CXCR4 Inhibition Impairs Development of Primary Lymphoma of the Central Nervous System. The American Journal of Pathology 193:8, pages 1101-1115.
Crossref
Crossref
Shunshun Bao, Mohammad Darvishi, Ali H Amin, Maysoon T. Al-Haideri, Indrajit Patra, Khadisha Kashikova, Irfan Ahmad, Fahad Alsaikhan, Zahraa Haleem Al-qaim, Moaed E. Al-Gazally, Bahman Abedi Kiasari, Bahareh Tavakoli-Far, Akmal A. Sidikov, Yasser Fakri Mustafa & Reza Akhavan-Sigari. (2023) CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. Journal of Cancer Research and Clinical Oncology 149:10, pages 7945-7968.
Crossref
Crossref
Sebastian DekkersBirgit CasparJoëlle Goulding, Nicholas D. KindonLaura E. Kilpatrick, Leigh A. StoddartStephen J. BriddonBarrie Kellam, Stephen J. Hill & Michael J. Stocks. (2023) Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of Medicinal Chemistry.
Crossref
Crossref
Xiangchou Yang, Yangyang Zhou, Linjing Huang, Shang Lin, Haihao Ye & Yujuan Shan. (2022) Fibroblast Common Serum Response Signature-Related Classification Affects the Tumour Microenvironment and Predicts Prognosis in Bladder Cancer. Oxidative Medicine and Cellular Longevity 2022, pages 1-29.
Crossref
Crossref
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, Laura Córdoba, Elena Maroto-Martín, Jessica Encinas, Alejandra Leivas, Paula Río & Joaquín Martínez-López. (2022) Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Frontiers in Immunology 13.
Crossref
Crossref
Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang & Bo Zhang. (2022) Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 14:8, pages 1541.
Crossref
Crossref
Kimia Ghasemi & Kosar Ghasemi. (2022) MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?. International Immunopharmacology 108, pages 108863.
Crossref
Crossref
Mahdieh Mehrpouri. (2022) The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies. European Journal of Pharmacology 920, pages 174831.
Crossref
Crossref
Elena Madrazo, Raquel González-Novo, Cándido Ortiz-Placín, Mario García de Lacoba, África González-Murillo, Manuel Ramírez & Javier Redondo-Muñoz. (2022) Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells. Oncogene 41:9, pages 1324-1336.
Crossref
Crossref
Aya Tal, Reshef Tal, Harvey J. Kliman & Hugh S. Taylor. (2021) Loss of Cxcr4 in Endometriosis Reduces Proliferation and Lesion Number while Increasing Intraepithelial Lymphocyte Infiltration. The American Journal of Pathology 191:7, pages 1292-1302.
Crossref
Crossref
Jaydeep Bhat, Anke K. Bergmann, Silvio Waschina, Christoph Nerl, Christoph Kaleta, Reiner Siebert, Ole Ammerpohl & Dieter Kabelitz. (2020) DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-α therapy. Cellular & Molecular Immunology 18:5, pages 1332-1335.
Crossref
Crossref
Daniel Cancilla, Michael P. Rettig & John F. DiPersio. (2020) Targeting CXCR4 in AML and ALL. Frontiers in Oncology 10.
Crossref
Crossref
Ashraf Mousavi. (2020) CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. Immunology Letters 217, pages 91-115.
Crossref
Crossref
Matthew T. Witkowski, Audrey Lasry, William L. Carroll & Iannis Aifantis. (2019) Immune-Based Therapies in Acute Leukemia. Trends in Cancer 5:10, pages 604-618.
Crossref
Crossref
Alessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, Krista Rombouts, Massimo Pinzani, Giulia Lori, Margherita Correnti, Pietro Invernizzi, Elisabetta Rovida, Nadia Navari, Sabina Di Matteo, Domenico Alvaro, Jesus M. Banales, Pedro Rodrigues, Carlotta Raschioni, Matteo Donadon, Luca Di Tommaso & Fabio Marra. (2019) CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865:9, pages 2246-2256.
Crossref
Crossref
Alessandra Righetti, Matteo Giulietti, Berina Šabanović, Giulia Occhipinti, Giovanni Principato & Francesco Piva. (2019) CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?. Journal of Oncology 2019, pages 1-13.
Crossref
Crossref
Qian Huang, Feifei Liu & Jianzhen Shen. (2019) The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights. Future Oncology 15:12, pages 1385-1395.
Crossref
Crossref
Frank Giordano, Barbara Link, Martin Glas, Ulrich Herrlinger, Frederik Wenz, Viktor Umansky, J. Brown & Carsten Herskind. (2019) Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12. Cancers 11:3, pages 272.
Crossref
Crossref
Derek W. Edwardson, Amadeo M. Parissenti & A. Thomas Kovala. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
173
215
.
Melody R. Becnel & Loretta J. Nastoupil. (2018) Follicular Lymphoma: Past, Present, and Future. Current Treatment Options in Oncology 19:7.
Crossref
Crossref
Haruka Sekiguchi, Tomoko Kuroyanagi, David Rhainds, Kazuya Kobayashi, Yuka Kobayashi, Hiroaki Ohno, Nikolaus Heveker, Kenichi Akaji, Nobutaka Fujii & Shinya Oishi. (2018) Structure–Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3). Journal of Medicinal Chemistry 61:8, pages 3745-3751.
Crossref
Crossref
Xianlong Gao, Lauren J. Albee, Brian F. Volkman, Vadim Gaponenko & Matthias Majetschak. (2018) Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. Scientific Reports 8:1.
Crossref
Crossref
Monica Gatti, Agnese Solari, Alessandra Pattarozzi, Chiara Campanella, Stefano Thellung, Lorella Maniscalco, Raffaella De Maria, Roberto Würth, Alessandro Corsaro, Adriana Bajetto, Alessandra Ratto, Angelo Ferrari, Antonio Daga, Federica Barbieri & Tullio Florio. (2018) In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Experimental Cell Research 363:1, pages 48-64.
Crossref
Crossref
Diana Hanekamp, Jacqueline Cloos & Gerrit Jan Schuurhuis. (2017) Leukemic stem cells: identification and clinical application. International Journal of Hematology 105:5, pages 549-557.
Crossref
Crossref
Lawrence M Agius. (2017) Dimensions of Niche-Induced Anti-Apoptosis of Therapeutically Resistant Neoplasms in Radio-Chemo-Therapy. International Journal of Radiology & Radiation Therapy 2:3.
Crossref
Crossref